Comprehensive genomics of cancer Flashcards

1
Q

What four classes of genomic alterations are distinguished by comprehensive genomic profiling? Give one example for each

A
  1. base substitutions: BRAF p.V600E
  2. insertions and deletions: EGFR exon 19 deletion in lung cancer
  3. copy number alterations: Amplification of HER2 in breast cancer
  4. rearrangements: ALK gene fusion and ABL gene fusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are copy number alterations?

A

somatic changes to the chromosome structure that result in a gain or loss of copies of DNA sections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are rearrangements?

A

either one fusion that preserves the proper complement of genetic information or complex, several fusions that disrupt the balance

Rearrangements occur via deletions, dublications, inversions and translocations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are microsatellites and why are they instable?

A

microsatellites are repetitive, highly preserved DNA sequence that occur through out the genome

They are prone to DNA- mismatching errors that occur during DNA replication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

which four genes are involved in mismatch repair? What happens if this system is inactivated?

A
  1. MLH1
  2. MSH2
  3. MSH6
  4. PMS2

–>inactivation leads to microsatellite instability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How can microsatellite instability be detected?

A

immunohistochemistry or PCR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is the tumor mutational burden (TMB)
(kr!)

A

TMB = number of somatic, non-synomous, coding base mutations that occur in a defined region of tumor genome. This high number of mutations is able to generate several neoantigens that can potenitally elicit immune response against tumor

–> immune evasion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

In which tumor is TMB observed?

A

PD-L1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

which mutations were associated with resistance to immunotherapeutic drugs?

A

STK11

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

how can targetable gene fusions be experimentally identified?

A

-RT-PCR
-NGS
-multiplex digital color coded barcode technology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which gene fusions make a patient eligable for tyrosine kinase inhibitor therapy?

A

gene fusions involving ALK or ROS1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What can help in assessing risk of malignancy? Name on example

A

identification of gene fusions

example: PAX8/PARG and RET/CCDC6 gene fusions are associated with thyroid cancer malignancies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What role do splice variants play in cancer therapy?

A

they have a predictive role. They also play a role in resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which gene test must be performed for an informed treatment decision in non-small cell lung cancer?

A

-PD-L1
-EGFR
-ALK
-ROS1 fusion protein
-BRAF V600E
-KRAS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which signaling pathways are turned on by ROS1 fusion proteins?

A
  1. PI3K –> AKT –> MTOR
  2. RAS –> RAF –> MEK –> ERK
  3. JAK –> STAT
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

describe the role of PD-L1 and what type of treatment can be used?

A

PD-L1 is a receptor expressed on tumor cells that can interact with PD1 receptors on T-cells

immunotherapy can be used

17
Q

Which rare mutations show a high sensitivity to cabozatinib and Larptrectinib in lung cancer?

A

RET, NTRK, MET (exon 14 skipping)

18
Q

Wich patients respond to afatinib treatment?

A

patients with NRG1 treatment

19
Q

Name biomarkers for breast cancer?

A

-ER
-PR
-HER2

20
Q

Name inhibitors that can be used to treat breast cancer

A
  1. PI3K inhibitor: alpesilib, fulvestrant
  2. PARP inhibitor
21
Q

Name mutations found in metastatic breast cancer who have a good survival chance and their role

A

-PI3KCA mutations -> activation of PI3K/AKT/mTOR pathway -> cell survival and proliferation
-germline BRCA1/2 mutations: homologous recombination deficiency
-HER2 amplifications
-MSI, NTRK translocation

22
Q

Match drug to cancer
1. alpesilib
2. fulvesant
3. cabozatinib
4. Larptrectinib
5. sunitinib and sorafenib
6. c-kit inhibitors
7. Larotrectinib and entrectinib

A
  1. breast cancer: PI3K inhibitor
  2. breast cancer: PI3K inhibitor
  3. lung cancer
  4. lung cancer
  5. gastrointestinal stromal tumors
  6. melanomas
  7. infantile fibrosarcoma
23
Q

How can BRCA1/2 mutations be inhibited?

A

By inhibiting PARP enzymes because PARP is needed for DNA repair of singla strand breaks. No repair leads to cell death

24
Q

Which mutation is found in half of all melanomas? What is the mechanism behind it?

A

BRAF mutations V600E and V600K
–> kinase activation ..> relief of intramolecular autoinhibitory interaction between the activation segment and the p-loop of the protein

25
Q

Name mutations in melonoma

A
  1. BRAF mutation
  2. C-kit
26
Q

Name mutations in gastrointestinal stromal tumors

A
  1. KIT
  2. PDGFRA